Skip navigation
Skip navigation

Reversible posterior encephalopathy syndrome associated with bortezomib

Terwiel, E; Hanrahan, R; Lueck, Christian; D'Rozario, James


Reversible posterior encephalopathy (RPES) is an uncommon neurological syndrome that is being increasingly reported in association with anti-neoplastic therapies. The first case of reversible posterior encephalopathy associated with the proteosome inhibitor bortezomib is described and the reported experience of the occurrence of RPES with other antineoplastic therapies reviewed. Dysregulation of cerebral vasomotor autoregulation is postulated as the underlying pathophysiology in this case of...[Show more]

CollectionsANU Research Publications
Date published: 2010
Type: Journal article
Source: Internal Medicine Journal
DOI: 10.1111/j.1445-5994.2009.02097.x


File Description SizeFormat Image
01_Terwiel_Reversible_posterior_2010.pdf419.91 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator